Stay updated on CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial
Sign up to get notified when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.

Latest updates to the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page
- CheckyesterdayChange DetectedThe history now shows Revision: v3.3.4 added and Revision: v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new record version (Revision: v3.3.3) was added and an older revision (Revision: v3.3.2) along with the HHS Vulnerability Disclosure link were removed from the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check44 days agoChange DetectedA 2025-11-25 update adds Contacts/Locations and Study Status (Revision: v3.3.2); this also removes the prior 2023-12-27 Revision: v3.3.1.SummaryDifference0.7%

- Check51 days agoChange DetectedRevision history updated: added v3.3.1 and removed v3.2.0 from the Study Record Versions.SummaryDifference0.1%

- Check58 days agoChange DetectedThe history shows removal of the government funding status notice that warned about potential delays and updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check73 days agoChange DetectedRecord History shows several updates, including the addition of IPDSharing in version 3 and subsequent updates to study status and contacts/locations through version 6.SummaryDifference0.1%

Stay in the know with updates to CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CLN-049 in AML/MDS Relapsed/Refractory Clinical Trial page.